Please read and agree to the
terms and conditions
of this site.
I agree
Medical Technology
/tech
Clear filters and search
Format
photo
Tags
abbvie
akouos
allergan
alnylam pharmaceuticals
amag pharmaceuticals
amunix
anirvan ghosh
astrazeneca
biogen
biotech
bluerock therapeutics
boston blog main
boulder/denver blog main
boulder/denver top stories
cancer
cancer immunotherapy
cerovene
clinical trials
covid-19
crispr
deals
deerfield management
detroit blog main
detroit top stories
durvalumab
editas medicine
europe blog main
europe top stories
fda
forty seven
fred hutch
general atlantic
gilead sciences
givosiran
imara
immunocore
indiana blog main
indiana top stories
inovio pharmaceuticals
ipo
What
daniel
2
×
deal
2
×
plans
years
acquisitions
algorithms
announced
bio
cancer
ceo
city
collabs
costs
covid
decided
far
gilead
gilead’s
healthcare
help
institute
introduce
ipo
i’m
joined
medicare
medicines
month
mother
national
new
o’day
personal
photo
public
retired
roundup
school
sciences
starting
Language
unset
Current search:
daniel
×
deal
×
@theverge.com
1 year ago
When healthcare is decided by algorithms, who wins?
@xconomy.com
4 years ago
Bio Roundup: Gilead’s $4.9B Deal, COVID-19 Collabs, IPO Plans & More
